Search clinical trials for: Dopamine Release

Total 8558 results

Novartis Pharmaceuticals

Not yet recruiting

NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer.

Metastatic Neuroendocrine Prostate Cancer
Lei Lei, MD

Recruiting

Neurofeedback-Based Digital Therapeutics for the Diagnosis and Treatment of ADHD in Children. (ADHD)

Attention Deficit Disorder With Hyperactivity | Executive Function Disorder

China
Hôpital le Vinatier

Not yet recruiting

Interaction Between Early Trauma and Odor-induced Dopamine Release (T-ODOR)

Trauma, Psychological
National Institute on Drug Abuse (NIDA)

Not yet recruiting

Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder

Methamphetamine-dependence | Methamphetamine Abuse
Sidney Kimmel Comprehensive Cancer Center at Johns...
United States Department of Defense; Prostate Cancer Foundation; Panbela Therapeutics

Recruiting

Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer

Prostate Cancer

United States
Shanghai Mental Health Center
Yantai University

Recruiting

Assessing Dopamine Transporter Occupancy in the Patients With Depression Brain With Toludesvenlafaxine Hydrochloride Extended-Release Tablets Using 11C-CFT Positron Emission Tomography (PET)

Major Depressive Disorder

China
Nimble Science Ltd.
MRM Health N.V.

Recruiting

Observational Small Intestine and Blood Fingerprint (SmIle) Study in Parkinson's Disease (SmIle)

Parkinson Disease

Canada
NLS Pharmaceutics

Not yet recruiting

A Eight-Week Study of NLS-2 (Mazindol Extended Release) in Participants With Narcolepsy Type 1 (AMAZE)

Narcolepsy Type 1 | Narcolepsy With Cataplexy
University Hospital, Strasbourg, France

Recruiting

EEG-MRI Imaging of Methylphenidate Effects in Adult ADHD and Attentional Symptoms in Mood Disorders (ImAteM-TDA)

Adult ADHD | Adult-onset ADHD With Mood Disorder

France
Hôpital le Vinatier

Recruiting

Investigating Stress-Induced Dopamine Release: a fMRI-PET Study (ISIDORE)

Stress Response

France
Parnassia Addiction Research Centre
Radboud University Medical Center; Columbia University; Academisch Medisch Centrum... and other collaborators

Not yet recruiting

Efficacy and Safety of Sustained-release Dexamphetamine in Patients With Moderate to Severe Cocaine Use Disorder

Cocaine Use Disorder
Central South University

Not yet recruiting

iTBS Can Increase Frontal Dopamine Release in PET Dopamine Imaging.

Schizophrenia

China
Mahidol University

Not yet recruiting

The Study of Efficacy and Safety of Generic Methylphenidate Prolong-released Comparison With Original

Adhd
Shanghai WD Pharmaceutical Co., Ltd.

Recruiting

Comparative Bioavailability Study of Carbidopa/Levodopa Extended-Release Tablets Under Fasting and Fed Conditions

Parkinson Disease

India
Medical College of Wisconsin

Recruiting

Optimizing Neurocognition With Whole Brain Radiation Therapy (WBRT) Using Upfront Pulsed Reduced Dose-Rate (PRDR) Technique

Brain Metastases

United States
Shanghai WD Pharmaceutical Co., Ltd.

Recruiting

A Study of the Efficacy and Safety of Carbidopa-Levodopa Extended-Release Tablets in Patients With Parkinson's Disease

Parkinson Disease

China
Rajesh Narendran
National Institute on Drug Abuse (NIDA)

Recruiting

[C-11]NPA PET-amphetamine in Cocaine Use Disorders

Cocaine Use Disorder

United States
Monash Medical Centre
Monash University

Recruiting

FASST - Fetal Alcohol Spectrum Stimulant Trial (FASST)

Fetal Alcohol Spectrum Disorders

Australia
Second Affiliated Hospital, School of Medicine,...

Recruiting

Clinical Study of Stalevo in the Treatment of Early Parkinson's Disease

Parkinson Disease

China
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

Nicotine Replacement Therapy, Counseling, Varenicline, and Bupropion for Smoking Cessation, the PISCES I Trial

Cigarette Smoking-Related Carcinoma

United States
Joshua A. Lile, Ph.D.
National Institute on Drug Abuse (NIDA)

Recruiting

Neurobehavioral Mechanisms of Cocaine Choice

Cocaine Use Disorder

United States
University of Maryland, College Park
National Institute of Mental Health (NIMH); University of Michigan; Seattle Children... and other collaborators

Recruiting

Treating Parents With ADHD and Their Young Children Via Telehealth: A Hybrid Type I Effectiveness-Implementation Trial (TPAC)

ADHD | Parenting

United States
Mayo Clinic
Lindner Center of HOPE

Recruiting

8 Week Multi-site Study of MYDAYIS® for Bipolar Depression

Bipolar Depression

United States
University of Minnesota
National Institute on Drug Abuse (NIDA)

Recruiting

Bupropion for the Prevention of Postpartum Smoking Relapse

Postpartum Smoking Relapse

United States
University of Rochester NCORP Research Base
National Cancer Institute (NCI)

Recruiting

Bupropion to Reduce Cancer Related Fatigue in Cancer Survivors

Be Diagnosed With Cancer and Have Completed Systemic Therapy

United States
Neutec Ar-Ge San ve Tic A.Ş

Recruiting

Efficacy and Safety of Modified Release Cefpodoxime Formulation in the Treatment of Acute Sinusitis.

Sinusitis | Rhinosinusitis | Sinus Infection | Sinusitis, Acute | Rhinosinusitis Acute

Turkey
Hospital de Clinicas de Porto Alegre
Federal University of Rio Grande do Sul; Conselho Nacional de Desenvolvimento... and other collaborators

Recruiting

Methylphenidate in Adults With Attention Deficit/Hyperactivity Disorder

Attention Deficit Disorder With Hyperactivity

Brazil
University of Illinois at Chicago
The University of Texas Health Science Center, Houston

Recruiting

Targeting Anhedonia in Cocaine Use Disorder

Anhedonia | Cocaine-Related Disorders

United States
Thomas Jefferson University

Active, not recruiting

Effectiveness of an Enhanced Tobacco Intervention Protocol Compared to Standard Treatment in Helping Head and Neck and Lung Cancer Patients Starting Treatment to Reduce Cigarette Use

Head and Neck Squamous Cell Carcinoma | Lung Non-Small Cell Carcinoma

United States
University of Minnesota

Suspended

Sustained Release Oral Formulation for Treatment of Parkinson's Disease

Idiopathic Parkinson Disease

United States
Janssen Research & Development, LLC

Completed

A Study to Evaluate the Efficacy, Pharmacokinetics, Safety and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression

Depressive Disorder, Treatment-Resistant

United States, China
Emalex Biosciences Inc.
Psyadon Pharma

Completed

Safety and Tolerability Comparison of Immediate and Controlled Release Formulations of Ecopipam

Healthy

United States
Novo Nordisk A/S

Active, not recruiting

A Research Study Comparing Wegovy to Other Weight Management Drugs in People Living With Obesity in America

Obesity

United States
Sheba Medical Center

Completed

The Effect of Methylphenidate Treatment in Familial Attention Deficit/Hyperactivity Disorder (ADHD)

ADHD Predominantly Inattentive Type | Attention Deficit/Hyperactivity Disorder Combined Type | ADHD Predominantly Hyperactivity Type | ADHD-not Other Specified

Israel
NeuroDerm Ltd.

Active, not recruiting

Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations (BouNDless)

Parkinson's Disease

United States, Israel, Spain, France, Russian Federation, Austria, Italy, Belgium, Czechia, Hungary, Netherlands, Poland, Portugal, Slovakia, Ukraine, United Kingdom
Tris Pharma, Inc.
Premier Research Group plc

Completed

Amphetamine Extended-Release Tablets in the Treatment of Adults With ADHD

ADHD

United States
Otsuka Pharmaceutical Co., Ltd.

Active, not recruiting

Specified Drug-use Survey on Abilify Prolonged Release Aqueous Suspension for IM Injection (Prevention of Relapse of Mood Episodes in BP)

Bipolar Disorder I

Japan
McMaster University
Purdue Pharma, Canada

Completed

A 14 Week, Randomized, Placebo-Controlled Cross-Over Study of Methylphenidate Hydrochloride Controlled Release Capsules in Adult ADHD With and Without Anxiety Disorder Comorbidity

Generalized Anxiety Disorder | Attention Deficit Hyperactivity Disorder | Social Anxiety Disorder | Panic Disorder | Agoraphobia

Canada
University of Nebraska

Completed

Bupropion in the Treatment of Methamphetamine Dependence

Methamphetamine Use Disorder

United States
University of California, Los Angeles

Withdrawn

Relapse Prevention in Stimulant Use Disorder

ADHD | Cognitive Function | Relapse | Stimulant Use

United States
University of Cincinnati
National Institute of Mental Health (NIMH)

Completed

Neuroimaging Study of Risk Factors for Adolescent Bipolar Disorder (NERF)

Attention Deficit Hyperactivity Disorder

United States
St. Joseph's Healthcare Hamilton
Bausch Health, Canada Inc.

Active, not recruiting

A Trial Evaluating the Effectiveness of Contrave in Patients Who Have Weight Recidivism Following Bariatric Surgery (COR-WR)

Obesity

Canada
St. Joseph's Healthcare Hamilton
Bausch Health, Canada Inc.

Active, not recruiting

Evaluating Contrave for Weight Maintenance in Adults With BMI >= 27 Kg/m2, After 6 Month Behaviour Modification Program. (COR-WM)

Obesity

Canada
Purdue Pharma LP

Terminated

Real-World Evidence of Duration of Effect of Adhansia XR (Extended-Release) for Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) (RE-DAX)

Attention-Deficit/Hyperactivity Disorder

United States
Shanghai Mental Health Center
Yantai University

Completed

Assessing Dopamine Transporter Occupancy in the Healthy Adult Brain With Toludivenlafaxine Hydrochloride Extended-Release Tablets Using 11C-CFT Positron Emission Tomography (PET)

Major Depressive Disorder

China
Pfizer
Pierre Fabre Laboratories

Active, not recruiting

Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors

Advanced Solid Tumors | Metastatic Melanoma

United States, Spain, Belgium, Canada, Netherlands
Massachusetts General Hospital

Completed

A Pilot of Methylphenidate in Mild Cognitive Impairment and Dementia Participants.

Alzheimer Dementia

United States
Luye Pharma Group Ltd.
Parexel

Completed

A Study to Evaluate the Effectiveness and Safety of LY03003 in Patients With Early Primary PD

Parkinson Disease

China
Titan Pharmaceuticals

Terminated

Relative Bioavailability Study of Ropinirole Implants in Parkinson's Patients on L-Dopa Switched From Oral Ropinirole

Parkinson Disease

United States
The Cleveland Clinic

Active, not recruiting

EMI-EHP Weight Management and Type 2 Diabetes Pragmatic Trial (EMPOWER-T2D)

Obesity | Type 2 Diabetes

United States

Search clinical trials for: Dopamine Release

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sweden

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations